Contraception:

It is recommended that women treated with methotrexate wait at least 3 months before trying to conceive again.

​

Future Fertility:

• In the absence of a history of subfertility or tubal pathology, women should be advised that there is no difference in the rate of fertility, the risk of future tubal ectopic pregnancy or tubal patency rates between the different management methods. [New 2016]

 

• Women with a previous history of subfertility should be advised that treatment of their tubal ectopic pregnancy with expectant or medical management is associated with improved reproductive outcomes compared with radical surgery. [New 2016]

 

• Women receiving methotrexate for the management of tubal ectopic pregnancy can be advised that there is no effect on ovarian reserve. [New 2016]
   

• Women undergoing treatment with uterine artery embolisation and systemic methotrexate for nontubal ectopic pregnancies can be advised that live births have been reported in subsequent pregnancies. [New 2016]
   

• Women undergoing laparoscopic management of ovarian pregnancies can be advised that their future fertility prospects are good. [New 2016]